API-D Deuterium Technologies was founded in Gatineau, Quebec in 2020 by a group of scientists with 20 years of experience in the field of stable isotopes specializing in development of very advanced techniques to produce deuterium-labeled Active Pharmaceutical Ingredients in innovative ways to by-pass inefficient and long conventional synthesis. This approach enables us to deliver high quality products to our clients much faster and cheaper than the other manufacturers employing lengthy and expensive conventional synthesis.
